drugset / Trial / NCT02185924

Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty

NCT02185924

Phase 2/3 Completed 90 enrolled Asklepieion Voulas General Hospital
RandomizedParallel-groupQuadruple-blind

Summary

Combination of continuous femoral block with parEcoxib vs placebo. Investigation of morphine consumption, opioid sparing effects, VAS pain scores, haemodynamics, Anxierty scores, transfusion requirements , Range of motion and rehabilitation parameters between two groups

Timeline

Start
2009-01
Primary completion
2011-09
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 40 mg Intravenous
Background Ropivacaine Other / unclassified 0.2 % Other

Indications

No indication recorded.